Who
Jeannette Bankes
CEO, Patient Care Solutions
Company insider
Files Form 4 as: CEO, Patient Care Solutions, GE HealthCare Technologies; Director, Atrion; Director, Apollo Endosurgery.
In numbers
- Trades disclosed
- 22
- Buys
- 0
- Sells
- 0
- Bought
- $0
- Sold
- $0
- Companies
- 3
- Companies where not an officer
- 2
- First trade
- 6 May 2022
- Last trade
- 1 Sep 2026
- Last filed
- 3 Sep 2026
Companies traded
Activity over time
Not enough dated trades to draw.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 1 Sep 2026filed 3 Sep 2026 | GEHC GE HealthCare TechnologiesMedical Devices | SEC FORM 4 Code F | $76K1,064 at $71.23 | filing |
| 1 Sep 2026filed 3 Sep 2026 | GEHC GE HealthCare TechnologiesMedical Devices | SEC FORM 4 Code F | $76K1,064 at $71.23 | filing |
| 15 May 2026filed 19 May 2026 | GEHC GE HealthCare TechnologiesMedical Devices | SEC FORM 4 Code F | $347K5,535 at $62.67 | filing |
| 15 May 2026filed 19 May 2026 | GEHC GE HealthCare TechnologiesMedical Devices | SEC FORM 4 Code F | $347K5,535 at $62.67 | filing |
| 2 Mar 2026filed 4 Mar 2026 | GEHC GE HealthCare TechnologiesMedical Devices | SEC FORM 4 Code A | —6,861 at $0.00 | filing |
| 2 Mar 2026filed 4 Mar 2026 | GEHC GE HealthCare Technologiesoption or derivative · Medical Devices | SEC FORM 4 Code A | —18,038 at $0.00 | filing |
| 2 Mar 2026filed 4 Mar 2026 | GEHC GE HealthCare Technologiesoption or derivative · Medical Devices | SEC FORM 4 Code A | —18,038 at $0.00 | filing |
| 2 Mar 2026filed 4 Mar 2026 | GEHC GE HealthCare TechnologiesMedical Devices | SEC FORM 4 Code A | —6,861 at $0.00 | filing |
| 15 May 2025filed 19 May 2025 | GEHC GE HealthCare Technologiesoption or derivative · Medical Devices | SEC FORM 4 Code A | —18,754 at $0.00 | filing |
| 15 May 2025filed 19 May 2025 | GEHC GE HealthCare TechnologiesMedical Devices | SEC FORM 4 Code A | —30,174 at $0.00 | filing |
| 15 May 2025filed 19 May 2025 | GEHC GE HealthCare TechnologiesMedical Devices | SEC FORM 4 Code A | —6,857 at $0.00 | filing |
| 21 Aug 2024filed 21 Aug 2024 | Atrionoption or derivative | SEC FORM 4 Code D | $144K312.51 at $460.00 | filing |
| 21 Aug 2024filed 21 Aug 2024 | Atrion | SEC FORM 4 Code D | $86K186 at $460.00 | filing |
| 21 May 2024filed 23 May 2024 | Atrionoption or derivative | SEC FORM 4 Code A | —311 at $0.00 | filing |
| 20 Sep 2023filed 21 Sep 2023 | Atrion | SEC FORM 4 Code A | $83K186 at $444.03 | filing |
| 4 Apr 2023filed 4 Apr 2023 | Apollo Endosurgeryoption or derivative | SEC FORM 4 Code D | —9,533 | filing |
| 4 Apr 2023filed 4 Apr 2023 | Apollo Endosurgeryoption or derivative | SEC FORM 4 Code D | —19,333 | filing |
| 4 Apr 2023filed 4 Apr 2023 | Apollo Endosurgery | SEC FORM 4 Code D | —17,641 | filing |
| 14 Jun 2022filed 16 Jun 2022 | Apollo Endosurgeryoption or derivative | SEC FORM 4 Code A | —19,333 at $0.00 | filing |
| 14 Jun 2022filed 16 Jun 2022 | Apollo Endosurgery | SEC FORM 4 Code A | —14,224 at $0.00 | filing |
News
No headline names them, or the companies they trade most, lately.
Sectors
No trade we could place in a sector.